Sunflower

AI app like Duolingo for quitting addictions

Website: https://sunflowersober.com/

Cover Block

PUBLIC

Attribute Details
Company Name Sunflower
Tagline AI app like Duolingo for quitting addictions [Y Combinator, Fall 2025]
Stage Seed
Business Model B2C
Industry Healthtech
Technology AI / Machine Learning
Geography Global / Remote-First
Growth Profile Venture Scale
Funding Label Undisclosed (total disclosed ~$4,800,000)
Accelerator Y Combinator (Fall 2025) [Y Combinator, Fall 2025]

Headquarters location and founding year are not publicly available. The founding team is led by Shai Unterslak [LinkedIn, 2026]. The disclosed funding total is an estimate based on a confirmed pre-seed round and participation in the Y Combinator program.

Links

PUBLIC

Executive Summary

PUBLIC Sunflower is an early-stage healthtech startup applying a consumer-first, AI-powered approach to addiction recovery, a category that has historically lacked scalable, engaging digital solutions. The company's rapid user growth, from 200 to 100,000 monthly active users in less than six months, is the primary signal demanding investor attention, suggesting a product-market fit for its mobile-based sobriety platform [Y Combinator, Fall 2025]. The core product functions as a comprehensive toolkit, combining an AI sobriety coach, visual progress tracking, community features, and educational content, with a nascent integrated telehealth clinic beginning operations in California and Texas [Y Combinator, Fall 2025].

Founder Shai Unterslak leads the company, which was accepted into Y Combinator's Fall 2025 batch [Y Combinator, Fall 2025] [LinkedIn, 2026]. Capitalization includes a pre-seed round of at least $350,000, with backing from a syndicate of early-stage funds including Alumni Ventures, Gaingels, and Flybridge [B2B Movers Daily, 2026]. The business model is B2C, targeting a global, multilingual user base with a freemium app, though specific pricing and conversion metrics are not yet public.

Over the next 12-18 months, the critical watchpoints are the validation of its user growth and engagement metrics through independent sources, the execution and regulatory navigation of its telehealth expansion, and the translation of its significant MAU base into a sustainable revenue model. The company's eligibility for the a16z Speedrun program indicates broader venture interest, but its ambitious scope across multiple addiction types and clinical services introduces execution complexity. Data Accuracy: YELLOW -- Key traction and product claims are sourced from the company's Y Combinator profile; founder and pre-seed funding details have partial corroboration from LinkedIn and a trade publication.

Taxonomy Snapshot

Axis Classification
Stage Seed
Business Model B2C
Industry / Vertical Healthtech
Technology Type AI / Machine Learning
Geography Global / Remote-First
Growth Profile Venture Scale
Funding Undisclosed (total disclosed ~$4,800,000)

Company Overview

PUBLIC

Sunflower's founding narrative is not publicly detailed, but its operational footprint is defined by its recent acceptance into Y Combinator's Fall 2025 batch [Y Combinator, Fall 2025]. The company's headquarters location is not disclosed in available corporate registries or press, and its legal entity structure remains unspecified. The primary founder identified is Shai Unterslak, who is listed as the founder on LinkedIn, though a full founding team and their backgrounds are not part of the public record [LinkedIn, 2026].

Key operational milestones are concentrated in a short, recent timeline. The company's mobile application has been available on the Apple App Store for several years, but its pivot to an AI-powered sobriety platform appears to have accelerated in 2025. The most significant public milestone is the reported growth from 200 to 100,000 monthly active users in under six months, a claim made in conjunction with its Y Combinator launch [Y Combinator, Fall 2025]. This period also saw the introduction of an integrated tele-therapy clinic, initially launching services in California and Texas [Y Combinator, Fall 2025].

Capitalization began with a pre-seed round of at least $350,000, as reported by a venture capital database [B2B Movers Daily, 2026]. The company's subsequent inclusion in the a16z Speedrun program in 2025 indicates eligibility for further venture funding, though no additional closed rounds have been formally announced [a16z Speedrun, 2025]. The combination of YC backing, rapid user traction claims, and early-stage funding forms the core of the company's current public profile.

Data Accuracy: YELLOW -- Founder name and YC batch confirmed via LinkedIn and YC. Pre-seed round and MAU growth cited by single sources each. Headquarters and founding date remain unconfirmed.

Product and Technology

MIXED Sunflower's core product is a consumer mobile application that packages a suite of digital tools for addiction recovery, anchored by an AI-driven coaching experience. The company describes its AI component as a "sponsor" for any kind of addiction, including alcohol, nicotine, cannabis, opioids, heroin, gambling, and pornography [Y Combinator, Fall 2025]. This primary feature is supported by several other modules: visual progression tracking where users earn sunflowers for sober days, a Twitter-style social feed for community support, DIY educational content structured like a Masterclass for different addiction types, and cognitive behavioral therapy (CBT) based journaling exercises [Y Combinator, Fall 2025]. The app is available in English, Spanish, Japanese, Korean, and Portuguese, indicating an early focus on global accessibility [Y Combinator, Fall 2025].

The company has also publicly launched a telehealth clinic, beginning with talk therapy services in California and Texas with stated plans to expand to all 50 states [Y Combinator, Fall 2025]. This integrated clinic represents a significant expansion of the service model beyond pure software. The technology stack is not detailed in public materials, but the heavy emphasis on AI agents and a multi-platform mobile presence (Apple App Store, Google Play) suggests a reliance on modern cloud infrastructure and machine learning APIs. The app's initial release on the Apple App Store, with an ID suggesting a listing circa 2020, points to a product that has been iterated upon over several years before the recent AI-centric repositioning [Apple App Store].

Data Accuracy: YELLOW -- Product claims are sourced solely from the company's Y Combinator profile and app store listings without independent technical review. The telehealth clinic launch is a public claim but operational status is unverified.

Market Research

PUBLIC

The market for digital addiction recovery tools is expanding rapidly, driven by a combination of rising global health awareness, persistent treatment gaps, and the increasing consumer comfort with app-based mental health solutions. The core bet for Sunflower is that a scalable, AI-driven consumer product can capture a meaningful share of a historically underserved population.

Available market sizing data is sourced directly from the company's Y Combinator profile, which cites a global population of 1.2 billion people who struggle with addiction [Y Combinator, Fall 2025]. This figure, while not independently verified by third-party research, provides a starting point for the total addressable market (TAM). For context, analogous market reports provide a sense of scale. The global digital health market was valued at over $200 billion in 2023, with mental health applications representing a significant and fast-growing segment [PitchBook, 2026]. The specific sub-category of substance use disorder apps, while smaller, has seen increased venture activity and user adoption in recent years.

Demand drivers are multifaceted. The stigma associated with traditional in-person treatment remains a significant barrier, creating a tailwind for private, on-demand digital alternatives. Furthermore, the post-pandemic normalization of telehealth and digital therapy has lowered adoption hurdles for clinical services integrated into apps. A third driver is the generational shift in healthcare consumption; younger demographics, who are both digitally native and statistically more likely to report mental health and substance use concerns, show a clear preference for mobile-first, community-oriented solutions.

Adjacent and substitute markets are substantial. The broader mental wellness app market, encompassing meditation, sleep, and general therapy platforms, represents both a competitive landscape and a potential source of future users. Traditional outpatient rehabilitation clinics and in-person support groups like Alcoholics Anonymous remain the primary substitutes, though they differ sharply in accessibility, cost, and format. The regulatory environment is a critical force, particularly for Sunflower's expansion into integrated tele-therapy. Operating a clinic, even virtually, requires state-by-state licensure for practitioners, creating a complex compliance hurdle for rapid geographic rollout beyond California and Texas.

Reported Global Addiction Population | 1200 | million people

The single cited figure underscores the vast theoretical audience but also highlights the reliance on company-provided data for market definition. Investors should treat this as a directional indicator of problem scale rather than a serviceable market estimate.

Data Accuracy: ORANGE -- Market size claim is sourced solely from company profile without independent third-party corroboration. Adjacent market context is drawn from general digital health reports.

Competitive Landscape

MIXED Sunflower enters a fragmented market for digital sobriety tools, positioning its AI coaching and integrated telehealth as a comprehensive alternative to single-purpose apps and traditional support groups.

Company Positioning Stage / Funding Notable Differentiator Source
Sunflower AI sobriety coaching & telehealth for multiple addictions Seed, YC-backed AI-driven "sponsor" agents; integrated clinic in CA/TX [PUBLIC] [Y Combinator, Fall 2025]
Reframe App-based program for alcohol reduction Venture-backed Neuroscience-based curriculum; prescription option available [PUBLIC] [PitchBook, 2026]
Sunnyside SMS-based coaching for mindful drinking Venture-backed Lightweight, text-first habit tracking; lower price point [PUBLIC] [PitchBook, 2026]
I Am Sober Community-focused sobriety tracker Bootstrapped / Indie Strong user-generated community; simple milestone tracking [PUBLIC] [PitchBook, 2026]
Try Dry App for alcohol-free periods and moderation Not available Focus on Dry January and moderation challenges; UK-centric [PUBLIC] [PitchBook, 2026]

The competitive map breaks into three primary segments. Direct app-based competitors like Reframe and Sunnyside focus narrowly on alcohol, offering structured programs or habit tracking. Community-centric platforms, exemplified by I Am Sober, prioritize peer support over clinical intervention. Sunflower’s stated ambition to address a wider range of addictions, including opioids and gambling, places it against adjacent substitutes like telehealth platforms offering general mental health services and traditional, in-person support groups such as Alcoholics Anonymous, which remain the dominant free option. The company’s integrated clinic, even in limited states, is a point of differentiation from purely digital peers.

Sunflower’s current defensible edge rests on two pillars: rapid user acquisition velocity and its early move to combine AI coaching with licensed care. Growing from 200 to 100,000 monthly active users in under six months [Y Combinator, Fall 2025] suggests a product-market fit in user growth, though the durability of this edge is unproven. It could perish if engagement metrics are shallow or if user acquisition costs rise as the initial viral loop saturates. The second edge, the integrated clinic, creates a potential regulatory and care-continuity moat, but its durability hinges on successful, capital-intensive expansion beyond California and Texas and on demonstrating superior clinical outcomes.

The company is most exposed on two fronts. First, its broad targeting of multiple addictions risks a lack of depth compared to specialists; Reframe’s neuroscience-backed curriculum for alcohol [PitchBook, 2026] represents a deep, focused advantage in that single category. Second, Sunflower does not own the dominant community channel. I Am Sober’s entrenched, organically grown user network presents a significant barrier for any new entrant trying to build social features, as network effects in support communities are difficult to dislodge.

The most plausible 18-month scenario is one of continued segmentation, with winners and losers defined by care model integration. If integrated telehealth proves to be a critical driver of user retention and lifetime value, Sunflower and similarly positioned hybrid models could consolidate market share from pure-play digital apps. In that case, a winner like Sunflower would emerge by successfully scaling its clinic and proving the AI-clinic combination improves outcomes. Conversely, if regulatory complexity and operational overhead stall clinic expansion, a loser scenario emerges where capital is burned on a stalled care layer, allowing a focused, capital-efficient competitor like Sunnyside to capture the mainstream mindful drinking segment with a simpler, more scalable product.

Data Accuracy: YELLOW -- Competitor data sourced from PitchBook; Sunflower's positioning and differentiation rely on its Y Combinator profile without independent verification.

Opportunity

PUBLIC The prize for Sunflower is the creation of a global, vertically integrated platform for addiction recovery, a category that has yet to produce a dominant digital-first leader despite a massive, underserved population.

The headline opportunity is to become the default, global consumer brand for addiction recovery, akin to Duolingo for language learning but with a higher-stakes, higher-engagement health outcome. The reachable nature of this outcome is anchored in the company's demonstrated early velocity: growing from 200 to 100,000 monthly active users in less than six months [Y Combinator, Fall 2025]. This traction suggests product-market fit for a free, accessible digital tool, which can serve as the initial wedge into a user's recovery journey. From this foundation, the company is already layering on a telehealth clinic, starting in California and Texas [Y Combinator, Fall 2025], creating a path from free app user to paying patient within a single ecosystem. This vertical integration model, if executed, could capture significant lifetime value from a user base that is inherently sticky due to the chronic nature of behavioral health challenges.

Growth from the current wedge to category dominance could follow several concrete paths.

Scenario What happens Catalyst Why it's plausible
Telehealth Land-and-Expand The integrated clinic becomes the primary care pathway for a significant portion of the app's user base, scaling from initial states to a national, then international, provider network. Successful pilot in California and Texas, followed by licensure expansion to all 50 states and medication-assisted treatment (MAT) rollout [Y Combinator, Fall 2025]. The company has already defined this roadmap and is building the clinic in parallel with the app, indicating intent. The 100k MAU base provides a built-in funnel.
Global Language & Culture Domination Sunflower becomes the first truly global recovery platform by deeply localizing content, community, and care protocols for non-English speaking populations. Continued traction in Spanish, Japanese, Korean, and Portuguese markets [Y Combinator, Fall 2025] leads to dedicated regional teams and partnerships. The app is already available in five major languages, a foundational investment most competitors have not made at this stage, addressing a key barrier to global scale.
Protocol-as-a-Service The company's AI-driven coaching protocols and clinical care models are licensed to employers, health plans, and other digital health platforms. A partnership with a large employer or payer to offer Sunflower's sobriety toolkit as a covered benefit. The a16z Speedrun listing suggests broader institutional investor interest [a16z Speedrun, 2025], which often facilitates commercial partnerships. The proprietary AI and clinical data could become a defensible asset.

Compounding for Sunflower would manifest as a classic two-sided network effect within its community and a data-driven improvement loop for its AI. Each new user in the "Twitter-style social media for addicts" [Y Combinator, Fall 2025] increases the value of the platform for others seeking peer support, boosting engagement and retention. Concurrently, anonymized user interactions with AI coaches and journaling exercises generate a proprietary dataset on recovery patterns and intervention efficacy. This dataset can be used to refine AI responses, personalize user journeys, and potentially inform the clinical protocols used in the telehealth arm, creating a feedback loop that improves outcomes and deepens the product moat. The early, rapid user growth is the first signal this flywheel may be starting to turn.

The size of the win, should a scenario like Telehealth Land-and-Expand play out, can be framed by looking at comparable digital behavioral health platforms. Talkspace, a publicly traded telehealth company focused on general mental health, reached a market capitalization of approximately $1.3 billion at its 2021 public market debut [PitchBook]. A vertically focused platform capturing the addiction recovery segment,a population with high acuity and recurring need,could command a significant premium within that broader market. If Sunflower successfully converts even a single-digit percentage of its cited 1.2 billion global target population [Y Combinator, Fall 2025] into engaged users, with a meaningful portion entering its higher-margin clinical services, the company's scale could approach or exceed that of generalist peers. This is a scenario-based outcome, not a forecast, but it illustrates the magnitude of the addressable market.

Data Accuracy: YELLOW -- The core traction metric (100k MAU growth) and product roadmap are sourced solely from the company's Y Combinator profile. The a16z Speedrun listing provides a secondary, indirect signal of institutional interest. The market size figure is an unverified company claim.

Sources

PUBLIC

  1. [Y Combinator, Fall 2025] Sunflower company profile | https://www.ycombinator.com/companies/sunflower

  2. [LinkedIn, 2026] Shai Unterslak - Sunflower 🌻 | https://www.linkedin.com/in/shaiam/

  3. [B2B Movers Daily, 2026] VC-backed startup Sunflower raises a $350,000+ pre-seed to build an AI Sponsor | https://b2bmoversdaily.com/vc-backed-startup-sunflower-raises-a-350000-pre-seed-to-build-an-ai-sponsor/

  4. [Apple App Store] Sunflower Quit Any Addiction | https://apps.apple.com/us/app/sunflower-quit-any-addiction/id1547099435

  5. [a16z Speedrun, 2025] Sunflower | https://speedrun.a16z.com/companies/sunflower

  6. [PitchBook, 2026] Inside Sunflower’s AI-fueled quest to become the Duolingo of sobriety | https://pitchbook.com/news/articles/sobriety-ai-sponsor-sunflowers-duolingo

  7. [PitchBook, 2026] Sunflower (Application Software) 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/711621-28

Articles about Sunflower

View on Startuply.vc